Zobrazeno 1 - 5
of 5
pro vyhledávání: '"A. D. Meringa"'
Autor:
A. D. Meringa, P. Hernández-López, A. Cleven, M. de Witte, T. Straetemans, J. Kuball, D. X. Beringer, Z. Sebestyen
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Externí odkaz:
https://doaj.org/article/adc4ef23bed647bca5b284ce5c416814
Autor:
Inez Johanna, Trudy Straetemans, Sabine Heijhuurs, Zsolt Sebestyen, Jürgen Kuball, Eline van Diest, Patricia Hernández López, Angelo D Meringa, Anna Vyborova, Froso Karaiskaki, Jan Gumathi Bormin, Sanne van Dooremalen, Mara J T Nicolasen, Lucrezia C D E Gatti, Dennis X Beringer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Externí odkaz:
https://doaj.org/article/de666a740e2143a1a08f52a3ccd29c36
Autor:
Johanna F. Dekkers, Maria Alieva, Astrid Cleven, Farid Keramati, Amber K. L. Wezenaar, Esmée J. van Vliet, Jens Puschhof, Peter Brazda, Inez Johanna, Angelo D. Meringa, Heggert G. Rebel, Maj-Britt Buchholz, Mario Barrera Román, Amber L. Zeeman, Sam de Blank, Domenico Fasci, Maarten H. Geurts, Annelisa M. Cornel, Else Driehuis, Rosemary Millen, Trudy Straetemans, Mara J. T. Nicolasen, Tineke Aarts-Riemens, Hendrikus C. R. Ariese, Hannah R. Johnson, Ravian L. van Ineveld, Froso Karaiskaki, Oded Kopper, Yotam E. Bar-Ephraim, Kai Kretzschmar, Alexander M. M. Eggermont, Stefan Nierkens, Ellen J. Wehrens, Henk G. Stunnenberg, Hans Clevers, Jürgen Kuball, Zsolt Sebestyen, Anne C. Rios
Publikováno v:
Nature Biotechnology. Nature Publishing Group
Extending the success of cellular immunotherapies against blood cancers to the realm of solid tumors will require improved in vitro models that reveal therapeutic modes of action at the molecular level. Here we describe a system, called BEHAV3D, deve
Autor:
van Vliet Ej, Hans Clevers, Wehrens Ej, Alieva M, Oded Kopper, Rebel Hg, Kai Kretzschmar, A. D. Meringa, Rios Ac, Yotam E. Bar-Ephraim, van Ineveld Rl, Peter Brazda, Domenico Fasci, Ariese Hc, Farid Keramati, Inez Johanna, Buchholz M, Henk Stunnenberg, Johanna F. Dekkers, J. Kuball, Karaiskaki E, Eggermont Am, Zsolt Sebestyén, Wezenaar Ak, Maarten H. Geurts, Román Mb, Jens Puschhof, Cleven A
SummaryCellular immunotherapies are rapidly gaining clinical importance, yet predictive platforms for modeling their mode of action are lacking. Here, we developed a dynamic immuno-organoid 3D imaging-transcriptomics platform; BEHAV3D, to unravel the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3449ee2bfa7051e711bd3325bf3838
https://doi.org/10.1101/2021.05.05.442764
https://doi.org/10.1101/2021.05.05.442764
Autor:
Eline van Diest, Froso Karaiskaki, Dennis X. Beringer, Sanne van Dooremalen, Jürgen Kuball, Zsolt Sebestyén, Jan Gumathi Bormin, Lucrezia C D E Gatti, Trudy Straetemans, Inez Johanna, Anna Vyborova, Sabine Heijhuurs, Patricia Hernández López, Mara J T Nicolasen, Angelo D Meringa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 11 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Backgroundγ9δ2 T cells hold great promise as cancer therapeutics because of their unique capability of reacting to metabolic changes with tumor cells. However, it has proven very difficult to translate this promise into clinical success.MethodsIn o